In this context, utilizing bioinformatics and network pharmacology methodologies, we have predicted the key targets and signaling pathways of ALC against PD, discovering that its mechanisms of action may be associated with the inhibition of apoptosis and the upregulation of the PKA/p-CREB/BDNF pathway. The gene discussed is CREB1; the disease is Parkinson disease.